These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 3742713)
21. Cellular resistance to chloroethylnitrosoureas, nitrogen mustard, and cis-diamminedichloroplatinum(II) in human glial-derived cell lines. Aida T; Bodell WJ Cancer Res; 1987 Mar; 47(5):1361-6. PubMed ID: 3469016 [TBL] [Abstract][Full Text] [Related]
22. Role of glutathione depletion in the mechanism of action of N-methylformamide and N,N-dimethylformamide in a cultured human colon carcinoma cell line. Cordeiro RF; Savarese TM Cancer Res; 1986 Mar; 46(3):1297-305. PubMed ID: 3943098 [TBL] [Abstract][Full Text] [Related]
23. Cytoskeleton-dependent surface blebbing induced by the polar solvent N-methylformamide. Malorni W; Meschini S; Arancia G Exp Mol Pathol; 1992 Oct; 57(2):85-104. PubMed ID: 1426160 [TBL] [Abstract][Full Text] [Related]
24. Induction of doxorubicin resistance in heterogeneous human colon tumor cells by N-methylformamide. Ferrari LA; Bliven SF; Wiemann M; Calabresi P; Glicksman AS; Leith JT Cancer Treat Rep; 1986 Oct; 70(10):1177-80. PubMed ID: 3756940 [TBL] [Abstract][Full Text] [Related]
25. [The effect of an injection of N-methylformamide into mice on the cell cycle and cell morphology of ascitic hepatoma 22A]. Proskuriakov SIa; Guliaev VA; Smoryzanova OA; Nikolaeva TG; Dobrynin IaV; Riabchenko NI Tsitologiia; 1996; 38(2):129-34. PubMed ID: 8754129 [TBL] [Abstract][Full Text] [Related]
26. Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma. Teicher BA; Herman TS; Tanaka J; Eder JP; Holden SA; Bubley G; Coleman CN; Frei E Cancer Res; 1991 Feb; 51(4):1086-91. PubMed ID: 1825474 [TBL] [Abstract][Full Text] [Related]
28. Cellular replication kinetics and persistence of sister chromatid exchange-inducing lesions in normal and lymphoma AKR cells following exposure to 1,3-bis(2-chloroethyl)-1-nitrosourea. Biegel JA; Conner MK; Boggs SS Cancer Res; 1982 Jul; 42(7):2816-20. PubMed ID: 7083172 [TBL] [Abstract][Full Text] [Related]
29. Investigations of the relationship between cell proliferation and differentiation of HL-60 cells induced to differentiate by N-methylformamide. Langdon SP; Richards FM; Hickman JA Leuk Res; 1988; 12(3):211-6. PubMed ID: 3163397 [TBL] [Abstract][Full Text] [Related]
30. Laboratory studies of berberine used alone and in combination with 1,3-bis(2-chloroethyl)-1-nitrosourea to treat malignant brain tumors. Zhang RX; Dougherty DV; Rosenblum ML Chin Med J (Engl); 1990 Aug; 103(8):658-65. PubMed ID: 2122945 [TBL] [Abstract][Full Text] [Related]
31. Potentiation of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)-induced cytotoxicity in 9L cells by pretreatment with 6-thioguanine. Bodell WJ; Morgan WF; Rasmussen J; Williams ME; Deen DF Biochem Pharmacol; 1985 Feb; 34(4):515-20. PubMed ID: 3970721 [TBL] [Abstract][Full Text] [Related]
32. Effect of caffeine on cytotoxicity and sister chromatid exchange induction in sensitive and resistant rat brain tumor cells treated with 1,3-bis(2-chloroethyl)-1-nitrosourea. Aida T; Bodell WJ Cancer Res; 1987 Oct; 47(19):5052-8. PubMed ID: 3621190 [TBL] [Abstract][Full Text] [Related]
33. Enhancement of antitumor activity of the oxazaphosphorine cytostatic SUM-IAP by N-methylformamide. Voelcker G J Cancer Res Clin Oncol; 2016 Jun; 142(6):1183-9. PubMed ID: 26941190 [TBL] [Abstract][Full Text] [Related]
34. Modification of tumor and normal tissue radioresponse in mice by N-methylformamide. Iwakawa M; Milas L; Hunter N; Tofilon PJ Int J Radiat Oncol Biol Phys; 1987 Jan; 13(1):55-60. PubMed ID: 3804817 [TBL] [Abstract][Full Text] [Related]
35. Effects of the differentiating agents sodium butyrate and N-methylformamide on the oxygen enhancement ratio of human colon tumor cells. Hallows KR; Bliven SF; Leith JT Radiat Res; 1988 Jan; 113(1):191-8. PubMed ID: 3340722 [TBL] [Abstract][Full Text] [Related]
36. Clinical pharmacology of oral and i.v. N-methylformamide: a pharmacologic basis for lack of clinical antineoplastic activity. Rowinsky EK; Noe DA; Orr DW; Grochow LB; Ettinger DS; Donehower RC J Natl Cancer Inst; 1988 Jul; 80(9):671-8. PubMed ID: 3373556 [TBL] [Abstract][Full Text] [Related]
37. Lonidamine as a modulator of alkylating agent activity in vitro and in vivo. Teicher BA; Herman TS; Holden SA; Epelbaum R; Liu SD; Frei E Cancer Res; 1991 Feb; 51(3):780-4. PubMed ID: 1988117 [TBL] [Abstract][Full Text] [Related]
38. [Effect of pretreatment with N-methyl-N-nitrosourea or streptozotocin on the cytotoxicity and the induction of sister chromatid exchanges in human and rodent brain tumor cells treated with chloroethylnitrosourea]. Tokuda K Hokkaido Igaku Zasshi; 1992 Jul; 67(4):462-74. PubMed ID: 1427592 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of O6-alkylguanine-DNA-alkyltransferase activity potentiates cytotoxicity and induction of SCEs in human glioma cells resistant to 1,3-bis(2-chloroethyl)-1-nitrosourea. Aida T; Cheitlin RA; Bodell WJ Carcinogenesis; 1987 Sep; 8(9):1219-23. PubMed ID: 3621461 [TBL] [Abstract][Full Text] [Related]
40. The effects of diethyldithiocarbamate on the hepatotoxic action and antitumor activity of N-methylformamide in mice. Masuda Y; Nakayama N; Yasoshima M Jpn J Pharmacol; 1986 Apr; 40(4):541-50. PubMed ID: 3016389 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]